Global Compounding Pharmacy Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	199 Pages	TechNavio	January, 2025	INF19584689

Best Price Guarantee
Price	from $2,500
Length	199 Pages
Publisher	TechNavio
Published Date	January, 2025
SKU	INF19584689

Compounding Pharmacy Market 2025-2029

The compounding pharmacy market is forecasted to grow by USD 1740.6 million during 2024-2029, accelerating at a CAGR of 2.2% during the forecast period. The report on the compounding pharmacy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of HRT fueling demand for compounded medications, increasing prevalence of hormonal imbalance problems, and government regulations and initiatives.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's compounding pharmacy market is segmented as below:

By Product

Topical medications
Oral medications
Parenteral medications
Others

By Therapeutic Area

Pain management
Hormone replacement
Dermal disorders
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising popularity of personalized medicines as one of the prime reasons driving the compounding pharmacy market growth during the next few years. Also, untapped opportunities in emerging markets and global shortage of essential drugs will lead to sizable demand in the market.

The report on the compounding pharmacy market covers the following areas:

Compounding Pharmacy Market sizing
Compounding Pharmacy Market forecast
Compounding Pharmacy Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading compounding pharmacy market vendors that include ACPHARM QUEENSLAND Pty Ltd., Advance Pharmacy, B.Braun SE, Doughertys Pharmacy, Fagron NV, Fresenius Kabi AG, Institutional Pharmacy Solutions, ITC Compounding Pharmacy, Lee Silsby Compounding Pharmacy, McGuff Co. Inc., Nephron Pharmaceuticals Corp., Olympia Pharmacy, PenCol Specialty Pharmacy, QuVa Pharma Inc., Rx3 Compounding Pharmacy, Triangle Compounding Pharmacy, Valor Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy LLC. Also, the compounding pharmacy market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Therapeutic Area; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Compounding Pharmacy Market 2019 - 2023; Historic Market Size - Data Table on Global Compounding Pharmacy Market 2019 - 2023 ($ million); 5.2 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ million); 5.3 Therapeutic Area segment analysis 2019 - 2023; Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 The AI impact on Global Compounding Pharmacy Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product: 8.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 8.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 8.3 Topical medications - Market size and forecast 2024-2029; Chart on Topical medications - Market size and forecast 2024-2029 ($ million); Data Table on Topical medications - Market size and forecast 2024-2029 ($ million); Chart on Topical medications - Year-over-year growth 2024-2029 (%); Data Table on Topical medications - Year-over-year growth 2024-2029 (%); 8.4 Oral medications - Market size and forecast 2024-2029; Chart on Oral medications - Market size and forecast 2024-2029 ($ million); Data Table on Oral medications - Market size and forecast 2024-2029 ($ million); Chart on Oral medications - Year-over-year growth 2024-2029 (%); Data Table on Oral medications - Year-over-year growth 2024-2029 (%); 8.5 Parenteral medications - Market size and forecast 2024-2029; Chart on Parenteral medications - Market size and forecast 2024-2029 ($ million); Data Table on Parenteral medications - Market size and forecast 2024-2029 ($ million); Chart on Parenteral medications - Year-over-year growth 2024-2029 (%); Data Table on Parenteral medications - Year-over-year growth 2024-2029 (%); 8.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Therapeutic Area: 9.1 Market segments; Chart on Therapeutic Area - Market share 2024-2029 (%); Data Table on Therapeutic Area - Market share 2024-2029 (%); 9.2 Comparison by Therapeutic Area; Chart on Comparison by Therapeutic Area; Data Table on Comparison by Therapeutic Area; 9.3 Pain management - Market size and forecast 2024-2029; Chart on Pain management - Market size and forecast 2024-2029 ($ million); Data Table on Pain management - Market size and forecast 2024-2029 ($ million); Chart on Pain management - Year-over-year growth 2024-2029 (%); Data Table on Pain management - Year-over-year growth 2024-2029 (%); 9.4 Hormone replacement - Market size and forecast 2024-2029; Chart on Hormone replacement - Market size and forecast 2024-2029 ($ million); Data Table on Hormone replacement - Market size and forecast 2024-2029 ($ million); Chart on Hormone replacement - Year-over-year growth 2024-2029 (%); Data Table on Hormone replacement - Year-over-year growth 2024-2029 (%); 9.5 Dermal disorders - Market size and forecast 2024-2029; Chart on Dermal disorders - Market size and forecast 2024-2029 ($ million); Data Table on Dermal disorders - Market size and forecast 2024-2029 ($ million); Chart on Dermal disorders - Year-over-year growth 2024-2029 (%); Data Table on Dermal disorders - Year-over-year growth 2024-2029 (%); 9.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 9.7 Market opportunity by Therapeutic Area; Market opportunity by Therapeutic Area ($ million); Data Table on Market opportunity by Therapeutic Area ($ million)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 11.9 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.10 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.11 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.12 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ million); Data Table on India - Market size and forecast 2024-2029 ($ million); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.13 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.14 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.15 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ million); Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 11.16 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ million); Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 ACPHARM QUEENSLAND Pty Ltd.; ACPHARM QUEENSLAND Pty Ltd. - Overview; ACPHARM QUEENSLAND Pty Ltd. - Product / Service; ACPHARM QUEENSLAND Pty Ltd. - Key offerings; SWOT; 14.5 Advance Pharmacy; Advance Pharmacy - Overview; Advance Pharmacy - Product / Service; Advance Pharmacy - Key offerings; SWOT; 14.6 B.Braun SE; B.Braun SE - Overview; B.Braun SE - Product / Service; B.Braun SE - Key news; B.Braun SE - Key offerings; SWOT; 14.7 Fagron NV; Fagron NV - Overview; Fagron NV - Business segments; Fagron NV - Key offerings; Fagron NV - Segment focus; SWOT; 14.8 Fresenius Kabi AG; Fresenius Kabi AG - Overview; Fresenius Kabi AG - Product / Service; Fresenius Kabi AG - Key offerings; SWOT; 14.9 Institutional Pharmacy Solutions; Institutional Pharmacy Solutions - Overview; Institutional Pharmacy Solutions - Product / Service; Institutional Pharmacy Solutions - Key offerings; SWOT; 14.10 ITC Compounding Pharmacy; ITC Compounding Pharmacy - Overview; ITC Compounding Pharmacy - Product / Service; ITC Compounding Pharmacy - Key offerings; SWOT; 14.11 McGuff Co. Inc.; McGuff Co. Inc. - Overview; McGuff Co. Inc. - Product / Service; McGuff Co. Inc. - Key offerings; SWOT; 14.12 Nephron Pharmaceuticals Corp.; Nephron Pharmaceuticals Corp. - Overview; Nephron Pharmaceuticals Corp. - Product / Service; Nephron Pharmaceuticals Corp. - Key offerings; SWOT; 14.13 Olympia Pharmacy; Olympia Pharmacy - Overview; Olympia Pharmacy - Product / Service; Olympia Pharmacy - Key offerings; SWOT; 14.14 PenCol Specialty Pharmacy; PenCol Specialty Pharmacy - Overview; PenCol Specialty Pharmacy - Product / Service; PenCol Specialty Pharmacy - Key offerings; SWOT; 14.15 Rx3 Compounding Pharmacy; Rx3 Compounding Pharmacy - Overview; Rx3 Compounding Pharmacy - Product / Service; Rx3 Compounding Pharmacy - Key offerings; SWOT; 14.16 Triangle Compounding Pharmacy; Triangle Compounding Pharmacy - Overview; Triangle Compounding Pharmacy - Product / Service; Triangle Compounding Pharmacy - Key offerings; SWOT; 14.17 Valor Compounding Pharmacy; Valor Compounding Pharmacy - Overview; Valor Compounding Pharmacy - Product / Service; Valor Compounding Pharmacy - Key offerings; SWOT; 14.18 Wedgewood Village Pharmacy LLC; Wedgewood Village Pharmacy LLC - Overview; Wedgewood Village Pharmacy LLC - Product / Service; Wedgewood Village Pharmacy LLC - Key offerings; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Therapeutic Area; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Compounding Pharmacy Market 2019 - 2023 ($ million); Exhibits25: Historic Market Size - Product Segment 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Product - Market share 2024-2029 (%); Exhibits37: Data Table on Product - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Product; Exhibits39: Data Table on Comparison by Product; Exhibits40: Chart on Topical medications - Market size and forecast 2024-2029 ($ million); Exhibits41: Data Table on Topical medications - Market size and forecast 2024-2029 ($ million); Exhibits42: Chart on Topical medications - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on Topical medications - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on Oral medications - Market size and forecast 2024-2029 ($ million); Exhibits45: Data Table on Oral medications - Market size and forecast 2024-2029 ($ million); Exhibits46: Chart on Oral medications - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Oral medications - Year-over-year growth 2024-2029 (%); Exhibits48: Chart on Parenteral medications - Market size and forecast 2024-2029 ($ million); Exhibits49: Data Table on Parenteral medications - Market size and forecast 2024-2029 ($ million); Exhibits50: Chart on Parenteral medications - Year-over-year growth 2024-2029 (%); Exhibits51: Data Table on Parenteral medications - Year-over-year growth 2024-2029 (%); Exhibits52: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits53: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits54: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits55: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits56: Market opportunity by Product ($ million); Exhibits57: Data Table on Market opportunity by Product ($ million); Exhibits58: Chart on Therapeutic Area - Market share 2024-2029 (%); Exhibits59: Data Table on Therapeutic Area - Market share 2024-2029 (%); Exhibits60: Chart on Comparison by Therapeutic Area; Exhibits61: Data Table on Comparison by Therapeutic Area; Exhibits62: Chart on Pain management - Market size and forecast 2024-2029 ($ million); Exhibits63: Data Table on Pain management - Market size and forecast 2024-2029 ($ million); Exhibits64: Chart on Pain management - Year-over-year growth 2024-2029 (%); Exhibits65: Data Table on Pain management - Year-over-year growth 2024-2029 (%); Exhibits66: Chart on Hormone replacement - Market size and forecast 2024-2029 ($ million); Exhibits67: Data Table on Hormone replacement - Market size and forecast 2024-2029 ($ million); Exhibits68: Chart on Hormone replacement - Year-over-year growth 2024-2029 (%); Exhibits69: Data Table on Hormone replacement - Year-over-year growth 2024-2029 (%); Exhibits70: Chart on Dermal disorders - Market size and forecast 2024-2029 ($ million); Exhibits71: Data Table on Dermal disorders - Market size and forecast 2024-2029 ($ million); Exhibits72: Chart on Dermal disorders - Year-over-year growth 2024-2029 (%); Exhibits73: Data Table on Dermal disorders - Year-over-year growth 2024-2029 (%); Exhibits74: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits75: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits76: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits77: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits78: Market opportunity by Therapeutic Area ($ million); Exhibits79: Data Table on Market opportunity by Therapeutic Area ($ million); Exhibits80: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits81: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits82: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits83: Chart on Geographic comparison; Exhibits84: Data Table on Geographic comparison; Exhibits85: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits86: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits87: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits90: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits91: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits94: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits95: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on India - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on India - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on South Korea - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on South Korea - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on Brazil - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on Brazil - Year-over-year growth 2024-2029 (%); Exhibits141: Market opportunity By Geographical Landscape ($ million); Exhibits142: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits143: Impact of drivers and challenges in 2024 and 2029; Exhibits144: Overview on criticality of inputs and factors of differentiation; Exhibits145: Overview on factors of disruption; Exhibits146: Impact of key risks on business; Exhibits147: Companies covered; Exhibits148: Company ranking index; Exhibits149: Matrix on companies position and classification; Exhibits150: ACPHARM QUEENSLAND Pty Ltd. - Overview; Exhibits151: ACPHARM QUEENSLAND Pty Ltd. - Product / Service; Exhibits152: ACPHARM QUEENSLAND Pty Ltd. - Key offerings; Exhibits153: SWOT; Exhibits154: Advance Pharmacy - Overview; Exhibits155: Advance Pharmacy - Product / Service; Exhibits156: Advance Pharmacy - Key offerings; Exhibits157: SWOT; Exhibits158: B.Braun SE - Overview; Exhibits159: B.Braun SE - Product / Service; Exhibits160: B.Braun SE - Key news; Exhibits161: B.Braun SE - Key offerings; Exhibits162: SWOT; Exhibits163: Fagron NV - Overview; Exhibits164: Fagron NV - Business segments; Exhibits165: Fagron NV - Key offerings; Exhibits166: Fagron NV - Segment focus; Exhibits167: SWOT; Exhibits168: Fresenius Kabi AG - Overview; Exhibits169: Fresenius Kabi AG - Product / Service; Exhibits170: Fresenius Kabi AG - Key offerings; Exhibits171: SWOT; Exhibits172: Institutional Pharmacy Solutions - Overview; Exhibits173: Institutional Pharmacy Solutions - Product / Service; Exhibits174: Institutional Pharmacy Solutions - Key offerings; Exhibits175: SWOT; Exhibits176: ITC Compounding Pharmacy - Overview; Exhibits177: ITC Compounding Pharmacy - Product / Service; Exhibits178: ITC Compounding Pharmacy - Key offerings; Exhibits179: SWOT; Exhibits180: McGuff Co. Inc. - Overview; Exhibits181: McGuff Co. Inc. - Product / Service; Exhibits182: McGuff Co. Inc. - Key offerings; Exhibits183: SWOT; Exhibits184: Nephron Pharmaceuticals Corp. - Overview; Exhibits185: Nephron Pharmaceuticals Corp. - Product / Service; Exhibits186: Nephron Pharmaceuticals Corp. - Key offerings; Exhibits187: SWOT; Exhibits188: Olympia Pharmacy - Overview; Exhibits189: Olympia Pharmacy - Product / Service; Exhibits190: Olympia Pharmacy - Key offerings; Exhibits191: SWOT; Exhibits192: PenCol Specialty Pharmacy - Overview; Exhibits193: PenCol Specialty Pharmacy - Product / Service; Exhibits194: PenCol Specialty Pharmacy - Key offerings; Exhibits195: SWOT; Exhibits196: Rx3 Compounding Pharmacy - Overview; Exhibits197: Rx3 Compounding Pharmacy - Product / Service; Exhibits198: Rx3 Compounding Pharmacy - Key offerings; Exhibits199: SWOT; Exhibits200: Triangle Compounding Pharmacy - Overview; Exhibits201: Triangle Compounding Pharmacy - Product / Service; Exhibits202: Triangle Compounding Pharmacy - Key offerings; Exhibits203: SWOT; Exhibits204: Valor Compounding Pharmacy - Overview